Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 13, 1999

View Archived Issues

New European Commission Structure Leaves Questions

U.S. FDA Gives First-Ever Approval To Proneuron For Spinal Cord Cell Therapy Test

UK Researchers Show Drug Reduces Tumor Blood Flow

Trials Begin For Bayer's 1st German Biotech Product

Chemunex Launches New Test For E. Coli In Drinking Water

Focus On New Peptide Could Herald Lifetime Flu Vaccine

NicOx Launches $34M IPO To Speed Up Its R&D Efforts

MediGene In-Licenses Its Phase II-Ready CHF Drug

Alchemia To Build Pilot Plant For Carbohydrate Production

Genetically Modified Tomato Gets 'Amber Light' From EU

Other News To Note

European Biotech Community Denounces

Inpharmatica Unveils Database On Structure-Function Relationships

VitaResc Extends Product Pipeline With SIRS Drug

Genset Finds Schizophrenia Gene Through Janssen Collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...